Core activity
Develop and bring to the clinic a proprietary epigenetically-based, autologous, multivalent cellular vaccine for cancer treatment
Non core activities
- Collaborate with Pharmas and Academias on outsourced pre-clinical and clinical projects in Immuno-Oncology.
- Services delivery for:
- immunomonitoring of cancer patients;
- epigenetic, phenotypic and molecular analyses of prognostic and predictive biomarkers;
- scientific consultancy on novel immuno-therapeutic strategies.
